Bioton (LTS:0DTR) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0DTR Bioton SA LTS:0DTR
64 GF Score
Price zł3.43
GF Value zł4.40
! 3 Warning Signs
View Full Analysis

What is Bioton Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bioton  (LTS:0DTR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bioton Cyclically Adjusted PS Ratio Related Terms


Bioton Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Bioton's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioton Cyclically Adjusted PS Ratio Chart

Bioton Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.79 0.81 0.86 0.93

Bioton Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.93 0.96 0.95 0.97

LTS:0DTR vs VRTX, REGN, MRNA: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Bioton's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioton Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bioton's Cyclically Adjusted PS Ratio falls into.


LTS:0DTR
64GF Score
Bioton SA LTS:0DTR
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioton Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bioton's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bioton's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.828/162.2800*162.2800
=0.828

Current CPI (Jun. 2026) = 162.2800.

Bioton Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.887 99.064 1.453
201612 0.073 100.366 0.118
201703 0.811 101.018 1.303
201706 0.999 101.180 1.602
201709 1.071 101.343 1.715
201712 1.331 102.564 2.106
201803 0.537 102.564 0.850
201806 0.990 103.378 1.554
201809 0.572 103.378 0.898
201812 0.459 103.785 0.718
201903 0.358 104.274 0.557
201906 0.842 105.983 1.289
201909 0.523 105.983 0.801
201912 0.629 107.123 0.953
202003 0.432 109.076 0.643
202006 0.584 109.402 0.866
202009 0.506 109.320 0.751
202012 1.060 109.565 1.570
202103 0.429 112.658 0.618
202106 0.425 113.960 0.605
202109 0.557 115.588 0.782
202112 0.487 119.088 0.664
202203 0.583 125.031 0.757
202206 0.560 131.705 0.690
202209 0.670 135.531 0.802
202212 0.903 139.113 1.053
202303 0.400 145.950 0.445
202306 0.571 147.009 0.630
202309 0.590 146.113 0.655
202312 0.553 147.741 0.607
202403 0.437 149.044 0.476
202406 0.589 150.997 0.633
202409 0.489 153.439 0.517
202412 0.905 154.660 0.950
202503 0.764 157.021 0.790
202506 0.930 157.509 0.958
202509 0.846 158.000 0.869
202512 0.750 158.320 0.769
202603 0.572 163.070 0.569
202606 0.828 162.280 0.828

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bioton (LTS:0DTR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.43 is trading 22.1% below its estimated GF Value™ of zł4.40.

Key valuation signals for LTS:0DTR:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: zł4.40 vs. price of zł3.43 (22.1% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the LTS:0DTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioton Business Description

Other Exchanges BIO:Poland7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
64GF Score

Get the complete analysis for LTS:0DTR

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.43
Price
zł4.40
GF Value